Revenio Group Oyj · OMXHEX:REG1V
Revenio Group Oyj — Q3 2024 Earnings Presentation
18 slides from Revenio Group Oyj's earnings presentation, Oct 31, 2024
Slide 1: Q3/2024 Interim Report
Q3/2024 INTERIM REPORT QUARTER OF VERY STRONG ORGANIC GROWTH CEO Jouni Toijala & CFO Robin Pulkkinen
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Revenio's shares. Revenio’s past performance is no guide to future performance, and persons needing advice should consult an independent financial adviser. This present
Slide 3: Presenting today
Presenting today Jouni Toijala Robin Pulkkinen CEO CFO Q 3 / 2 0 2 4
Slide 4: Agenda
Agenda Highlights of Q3/2024 Financials Shareholders and financial guidance Q 3 / 2 0 2 4
Slide 5: July – September 2024 highlights
July – September 2024 highlights • Net sales totaled EUR 23.9 (22.0) million, an increase of 8.9% • The currency-adjusted growth of net sales in July-September was 15.1% • Operating profit was EUR 5.5 (6.0) million, or 23.0% of net sales, Net sales EBIT down by 8.5% 23.9 5.5 • EBITDA was EUR 6.7 (7.
Slide 6: January – September 2024 highlights
January – September 2024 highlights • Net sales totaled EUR 73.0 (67.4) million, an increase of 8.2% • The currency-adjusted growth of net sales in January– September was 8.9% • Operating profit was EUR 15.9 (16.9) million, or 21.8% of net Net sales EBIT sales, down by 5.6% 73.0 15.9 • EBITDA was EU
Slide 7: Business highlights of Q3/2024
Business highlights of Q3/2024 Sales of fundus imaging devices saw double- Revenio Group’s subsidiary Icare Finland Oy digit growth year-on-year. Of our main and the Dutch company Thirona B.V. signed products, the iCare EIDON product family and an agreement transferring ownership of the iCare DRSplu
Slide 8: ST500 slit-lamp tonometer
ST500 slit-lamp tonometer • iCare ST50 slit lamp tonometer was launched in September • The device brings the key elements of the iCare rebound technology within the slit lamp-based tonometer • iCare ST500 can provide comparable results to the current gold standard (GAT), without disadvantages • iCar
Slide 9: Financials
Financials Robin Pulkkinen CFO
Slide 10: Development of Revenio's key figures
Development of Revenio’s key figures Change- Change- MEUR 7-9/2024 7-9/2023 1-9/2024 1-9/2023 % % - We are satisfied with our sales Net sales 23.9 22.0 8.9 73.0 67.4 8.2 performance in the third quarter, Gross margin 16.5 15.6 6.3 51.2 47.7 7.3 although exchange rates Gross margin, % 69.1 70.8 -1.7
Slide 11: Quarter of very strong organic growth
Quarter of very strong organic growth Net sales (EUR million) 35 1,2 30 28,3 29,1 - Our exchange rate-adjusted net 24,4 23,2 22,3 23,6 25,4 23,9 1 sales grew 6.2 percentage points 24,1 25 23,8 20,2 22,0 0,8 faster than the reported growth. 19,4 20 0,6 15 - The exchange rate impact on our 10 0,4 sale
Slide 12: Profitability slightly down year over year
Profitability slightly down year over year Adjusted operating profit EUR million and % (EBIT) - Cost increases year over year are mostly related to higher bonus 10 33,1 9,5 35 accruals and salaries as well as 9 30,7 32,6 31,7 32,6 marketing costs related to new 27,5 29,2 8 7,7 7,7 9,3 26,6 28,1 30 p
Slide 13: Year to date net cash flow from operations on a record level
Year to date net cash flow from operations on a record level Net cash flow from operating activities (EUR million) - The year-to-date net cash flow from operations up 150% year over year. 14 11,7 12 11,0 - The net cash flow from 10 operations during the beginning of the year was improved by 8 7,1 ef
Slide 14: Balance sheet continues to get stronger
Balance sheet continues to get stronger Equity ratio and net gearing (%) 80,0 74,5 74,7 76,3 15,0 - Equity ratio continued to improve, 72,7 67,4 67,4 71,1 72,2 and the balance sheet provides us 70,0 66,8 10,0 64,0 11,2 63,0 66,2 7,0 64,0 financial flexibility in the future. 60,0 5,0 1,9 50,0 -1,1 0,
Slide 15: Shareholders on September 30, 2024
Shareholders on September 30, 2024* No. of % Verified shares 1. William Demant Invest A/S 5,059,383 18.96% 2024-09-30 Finnish ownership Foreign ownership 2. SEB Funds 1,084,304 4.06% 2024-09-30 47.75% 52.25% 3. Vanguard 906,618 3.40% 2024-09-30 4. Swedbank Robur Funds 759,000 2.84% 2024-08-31 Owner
Slide 16: Financial guidance
Financial guidance Net sales Financial guidance for 2024 (published on February 15, 2024) 97,0 96,6 78,8 Revenio Group’s exchange rate- adjusted net sales are estimated to 61,1 grow 5-10 percent from the previous year and profitability, 49,5 excluding non-recurring items, is estimated to remain at a
Slide 17: Revenio 2024
2024 REVENIO
Slide 18: We aspire to keep the wonderful world visible for all
“We aspire to keep the wonderful world visible for all”